TTR and amyloidosis: This crystal structure provides a structural basis for the clinically observed interactions of similar phenylanthranilic acids (e.g., flufenamic acid) with TTR [4] and provides a template for the design of TTR stabilizers for the prevention of TTR amyloidosis.